Is it Last Christmas for glitter?

Why is the EU trying to ban glitter? And what does it mean for people who like sparkly Christmas decorations, cards, toys, and wrapping paper?

Drug analysis – mastering the matrix

We assess the benefits and drawbacks of using saliva, hair, and sweat matrix materials for identifying and quantifying drugs and their metabolites.

Testing, testing: the need for constant vigilance on pesticide food residues

Despite concerns about their health and environmental effects, more pesticides are likely to be used in future – meaning that accurate testing for banned, unauthorised or restricted compounds is even more vital now than ever.

Breast cancer awareness month: new frontiers in targeting cancer metabolism

To mark Breast Cancer Awareness Month, we highlight new research showing how breast cancer cells rely on specific metabolic pathways for growth and metastasis, paving the way for an effective multimodal treatment strategy.

Sports doping and antidoping – a brief history

Athletes have been ‘doping’ – or taking performance enhancing substances – for over 2,000 years, but antidoping science and regulation only really began in in the late 20th century.

Fabulous at 40 – a fact for every year of LGC AXIO Proficiency Testing

The story of LGC AXIO Proficiency Testing began 40 years ago, in 1984. Here’ s all you need to know about us, in just 40 facts.

The solubility revolution: nanotechnology in drug delivery

Nanotechnology is revolutionising drug delivery by tackling the solubility and bioavailability challenges that lead to many drugs failing clinical trials.

LGC Analytical Quality training courses

We provide courses on topics such as method validation, measurement uncertainty, statistics and more, all designed to help laboratories ensure the reliability of their results and meet accreditation and regulatory requirements.

WHO releases new guidelines for preventing nitrosamine contamination

The World Health organisation (WHO) has released new recommendations for limiting the presence of potentially carcinogenic nitrosamine impurities in medicines.

Celebrating E7130: pushing the limits of complex drug synthesis

Drug discovery has reached another significant milestone with the large-scale synthesis of E7130 – an unprecedentedly complex anticancer drug candidate.

The global pesticides picture: Plus ça change...

What do recent political and regulatory developments mean for laboratories that analyse the environmental impact of pesticides?

Ibuprofen: the global painkiller with ‘great promise’, 60 years on

Ibuprofen has become a household staple and “a bedrock of pain relief and fever treatment all over the world.” But how did ibuprofen come to exist, and what does the future hold for it?

Analysing VOCs and SVOCs: LGC Standards’ solutions for cleaner air

What exactly are VOCs and SVOCs? How do they threaten human health and the environment? And what regulations have been implemented to reduce their risks?

Cannabis legalisation: what does it mean for Germany, and Europe?

It’s been described as “a historic moment”, but is cannabis legalisation in Germany here for the long term? And what will be the consequences for Germany’s people and economy?

How to read a COA for TRC Products

World Parkinson’s Day: Join the Movement to End Parkinson’s disease!

To mark World Parkinson's Day, LGC pays tribute to the scientists who work tirelessly to understand the disease’s molecular mechanisms, and to develop life-changing treatments.

New class of drugs effective against SARS-COV-2 and many RNA viruses

A new class of drugs could have the potential to prevent and treat a number of future viruses, including new coronavirus variants.

Getting to grips with the PFAS problem

With regulatory, scientific and public scrutiny all increasing, we’re starting to get to grips with PFAS pollution.